Search

Your search keyword '"Tse, Eric"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Tse, Eric" Remove constraint Author: "Tse, Eric" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
159 results on '"Tse, Eric"'

Search Results

1. Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer’s disease fold

2. The p97/VCP adaptor UBXD1 drives AAA+ remodeling and ring opening through multi-domain tethered interactions

5. Stacked binding of a PET ligand to Alzheimer’s tau paired helical filaments

6. Unique structural features govern the activity of a human mitochondrial AAA+ disaggregase, Skd3.

12. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

13. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

22. S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY.

23. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

24. Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region.

27. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

28. Asymmetric apical domain states of mitochondrial Hsp60 coordinate substrate engagement and chaperonin assembly

29. Mutations of ATM Confer a Risk of Inferior Survival in Patients with TP53-wild Type Mantle Cell Lymphoma

31. Nodular Lymphocyte Predominant Hodgkin Lymphoma with Splenic Involvement Is Characterized By Inflamed Tumor Microenvironment, High Expression of Checkpoint Molecule Gene-Signature and Adverse Outcome

34. P115: Distinct signaling pathways and checkpoint molecule expression across histological subtypes of nodular lymphocyte-predominant Hodgkin lymphoma

36. Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents

38. Epigenetic silencing of PTEN and epi-transcriptional silencing of MDM2 underlied resistance to hypomethylating agents in myelodysplastic syndrome

41. 36-Month Clinical Outcomes of Patients with Venous Thromboembolism: GARFIELD-VTE

47. ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis

48. The Atlas of Blood Cancer Genomes (ABCG) Project: A Comprehensive Molecular Characterization of Leukemias and Lymphomas

49. Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLL

Catalog

Books, media, physical & digital resources